Practice Guidelines Reviews - AUA 2023 UTUC

Risk Stratification and Pre-Surgical Assessments According to AUA Guidelines for Upper Tract Urothelial Carcinoma, Journal Club - Rashid Sayyid & Zachary Klaassen

Details
Rashid Sayyid and Zach Klaassen explore the AUA guidelines on diagnosing and managing non-metastatic upper tract urothelial carcinoma. Dr. Sayyid outlines the disease's background, emphasizing its rarity and higher risk of advanced presentation compared to bladder urothelial carcinoma. He also covers risk factors like chronic inflammation and Lynch syndrome, and delves into diagnostic procedures s...

Unpacking the AUA Guidelines: Neoadjuvant Chemotherapy and Surveillance in Non-Metastatic Upper Tract Urothelial Carcinoma, Journal Club - Rashid Sayyid & Zachary Klaassen

Details
Rashid Sayyid and Zach Klaassen examine the published AUA guidelines for diagnosing and managing non-metastatic upper tract urothelial carcinoma. The conversation spans a wide array of topics including neoadjuvant and adjuvant chemotherapy, immunotherapy, surveillance, and survivorship. Dr. Sayyid focuses on the strong recommendation for cisplatin-based neoadjuvant chemotherapy, especially for hig...

Exploring Kidney-Sparing Management: An In-Depth Look at Tumor Ablation Techniques, AUA Guidelines, and the Role of Jelmyto in Upper Tract Urothelial Carcinoma, Journal Club - Rashid Sayyid & Zachary...

Details
In a discussion about the published AUA guidelines on non-metastatic upper tract urothelial carcinoma, Rashid Sayyid and Zach Klaassen explore a wide array of treatment options and considerations. Dr. Sayyid focuses on giving patients a comprehensive understanding of both short-term and long-term risks associated with diagnostic and therapeutic choices, including kidney-sparing options like tumor...